Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Interleukin-2 × 1 year × Clear all

Sponsor

Conditions

Melanoma 18 Neoplasm Metastasis 8 Ovarian Neoplasms 7 Lymphoma, Non-Hodgkin 7 Colorectal Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Uveal Melanoma 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Recurrence 3 Multiple Myeloma 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Leukemia 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Mesothelioma, Malignant 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡